AstraZeneca shares tumble 15% on big drug trial setback – Financial Times

AstraZeneca shares tumble 15% on big drug trial setback – Financial Times
Financial TimesAstraZeneca shares tumble 15% on big drug trial setbackFinancial TimesShares in AstraZeneca faced their biggest one-day fall after the Anglo-Swedish pharmaceuticals company suffered a huge setback with a much-awaited trial of a new lung cancer drug failing to show the benefits the company had hoped for. The study, known …AstraZeneca shares dive after failure of key lung cancer drug trialThe GuardianShares in pharma giant AstraZeneca plunge more than 15% after lung cancer drug trial setbackBusiness InsiderAstraZeneca shares plunge 15 percent as lung cancer study failsReutersIrish Times -TheStreet.comall 46 news articles »
AstraZeneca shares tumble 15% on big drug trial setback – Financial Times